Javascript must be enabled to continue!
ESTIMATION AND TO KNOW THE ASSOCIATION OF AUTOANTIBODIES WITH DERMATOLOGICAL DISORDERS IN PATIENTS ATTENDING DERMATOLOGY OUTPATIENT DEPARTMENT
View through CrossRef
Background: The presence of antinuclear antibodies (ANA) is mainly associated with autoimmune diseases and connective tissue diseases
(CTD). In addition, their presence is found in healthy people. While the actual frequency of positive assays in healthy individuals varies with
methodology, nevertheless, up to 20% or more of otherwise healthy people can express an ANA. The basis of this seropositivity is puzzling. One
possibility is that ANAreactivity represents vagaries of the assays, allowing the detection of antibodies of either low titer or low avidity. ANAand
Anti double-stranded DNA (Anti-ds-DNA) antibodies in dermatological disorders other than CTD, and Vasculitis were not studied till now to our
knowledge. Hence this study has been taken up. Aim: Estimation and to know the association, of autoantibodies with dermatological disorders, to
better understand the diseases in patients attending the dermatology outpatient department (OPD).
Objectives:
1. To nd out the percentage of positivity for ANAby the Indirect Immunouorescent Assay (IFA) method.
2. To nd out the percentage of positivity for anti-ds DNAantibodies by the Enzyme-Linked Immunosorbent Assay (ELISA) method.
3. Percentage of positivity of both ANAand Anti-ds DNAantibodies in patients with dermatological problems.
4. To know the association of autoimmunity with various dermatological disorders for a better understanding of these disorders.
Materials & Methods:
Ahundred patients were selected after taking written informed consent and after inclusion and exclusion criteria got fullled. Details of the patients
were entered in the case record form and later were uploaded in a Microsoft excel sheet. One millilitre of the venous blood sample was drawn in
adults of each of the age categories 18-27, 28-37, 38-47, and 48-57. The upper age limit of 57 is selected for the sake of convenience. Sera were
analysed for ANAand Anti ds DNAantibodies by using IFAand ELISAmethods respectively. Results were recorded and analysed. Results: In a
total of 100 patients 11% and 13% were positive for ANA and Anti ds DNA respectively. For ANA and Anti ds DNA positivity the mean age was
34.5 ± 12.5 and 40.7 ± 10.7 respectively and females outnumbered males in both. Both ANAand Anti ds DNAwere positive in 3% of which all were
females with a mean age of 41 ± 9. ANA positivity was found commonly in Telogen efuvium (3), melasma (2), and Tinea (2). Anti-ds DNA
positivity was found commonly in Miliaria Rubra (2), and Tinea (2). Both ANAand Anti ds DNA were positive in telogen efuvium, melasma and
tinea. Conclusion:ANA, Anti ds DNA, both ANAand Anti ds DNAwere positive in otherwise healthy dermatological patients with diagnoses like
telogen efuvium, melasma, tinea, miliaria etc., to the extent of 11%, 13%, and 3% respectively. It is not known if autoantibody positivity in these
diseases is just a chance association or if the autoimmune mechanism got triggered by these diseases. Prospective longitudinal studies are
necessary to conrm these nding
Title: ESTIMATION AND TO KNOW THE ASSOCIATION OF AUTOANTIBODIES WITH DERMATOLOGICAL DISORDERS IN PATIENTS ATTENDING DERMATOLOGY OUTPATIENT DEPARTMENT
Description:
Background: The presence of antinuclear antibodies (ANA) is mainly associated with autoimmune diseases and connective tissue diseases
(CTD).
In addition, their presence is found in healthy people.
While the actual frequency of positive assays in healthy individuals varies with
methodology, nevertheless, up to 20% or more of otherwise healthy people can express an ANA.
The basis of this seropositivity is puzzling.
One
possibility is that ANAreactivity represents vagaries of the assays, allowing the detection of antibodies of either low titer or low avidity.
ANAand
Anti double-stranded DNA (Anti-ds-DNA) antibodies in dermatological disorders other than CTD, and Vasculitis were not studied till now to our
knowledge.
Hence this study has been taken up.
Aim: Estimation and to know the association, of autoantibodies with dermatological disorders, to
better understand the diseases in patients attending the dermatology outpatient department (OPD).
Objectives:
1.
To nd out the percentage of positivity for ANAby the Indirect Immunouorescent Assay (IFA) method.
2.
To nd out the percentage of positivity for anti-ds DNAantibodies by the Enzyme-Linked Immunosorbent Assay (ELISA) method.
3.
Percentage of positivity of both ANAand Anti-ds DNAantibodies in patients with dermatological problems.
4.
To know the association of autoimmunity with various dermatological disorders for a better understanding of these disorders.
Materials & Methods:
Ahundred patients were selected after taking written informed consent and after inclusion and exclusion criteria got fullled.
Details of the patients
were entered in the case record form and later were uploaded in a Microsoft excel sheet.
One millilitre of the venous blood sample was drawn in
adults of each of the age categories 18-27, 28-37, 38-47, and 48-57.
The upper age limit of 57 is selected for the sake of convenience.
Sera were
analysed for ANAand Anti ds DNAantibodies by using IFAand ELISAmethods respectively.
Results were recorded and analysed.
Results: In a
total of 100 patients 11% and 13% were positive for ANA and Anti ds DNA respectively.
For ANA and Anti ds DNA positivity the mean age was
34.
5 ± 12.
5 and 40.
7 ± 10.
7 respectively and females outnumbered males in both.
Both ANAand Anti ds DNAwere positive in 3% of which all were
females with a mean age of 41 ± 9.
ANA positivity was found commonly in Telogen efuvium (3), melasma (2), and Tinea (2).
Anti-ds DNA
positivity was found commonly in Miliaria Rubra (2), and Tinea (2).
Both ANAand Anti ds DNA were positive in telogen efuvium, melasma and
tinea.
Conclusion:ANA, Anti ds DNA, both ANAand Anti ds DNAwere positive in otherwise healthy dermatological patients with diagnoses like
telogen efuvium, melasma, tinea, miliaria etc.
, to the extent of 11%, 13%, and 3% respectively.
It is not known if autoantibody positivity in these
diseases is just a chance association or if the autoimmune mechanism got triggered by these diseases.
Prospective longitudinal studies are
necessary to conrm these nding.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Autoantibodies predict type 1 diabetes after gestational diabetes – a 23-year cohort study
Autoantibodies predict type 1 diabetes after gestational diabetes – a 23-year cohort study
ObjectiveTo study the predictive value of autoantibodies for type 1 (T1DM) and type 2 (T2DM) diabetes morbidity after gestational diabetes (GDM) in a 23-year follow-up study.Design...
Magnitude and pattern of scabies among patients attending dermatology clinic of ALERT hospital; Addis Ababa, Ethiopia
Magnitude and pattern of scabies among patients attending dermatology clinic of ALERT hospital; Addis Ababa, Ethiopia
Abstract
Background
Scabies is a global public health problem and the highest prevalence of scabies occurs in tropical area, es...
Profile of pyoderma in dermatology outpatient departement at Sanglah General Hospital Denpasar, Bali-Indonesia period January 2016 until December 2017
Profile of pyoderma in dermatology outpatient departement at Sanglah General Hospital Denpasar, Bali-Indonesia period January 2016 until December 2017
Introduction: Pyodermas are infections in the epidermis, just below the stratum corneum or in hair follicles. It is most common in children, although it can also affect adults. Pyo...
OR23-05 Acquired Osteomalacia Associated with Autoantibodies against PHEX
OR23-05 Acquired Osteomalacia Associated with Autoantibodies against PHEX
Abstract
Disclosure: Y. Hoshino: None. K. Okamoto: None. K. Hajime: None. K. Irie: None. S. Kimura: None. N. Hidaka: None. D. Hagiwara: None. M. Nangaku: Dr. Nang...
Prevalence survey of dermatological conditions in mountainous north India
Prevalence survey of dermatological conditions in mountainous north India
AbstractBackground Dermatological conditions account for a substantial proportion of the global burden of disease in low and middle income countries (Bickers D, Lim H, Margolis D,...
Evaluation of multiple autoantibodies to tumor-associated antigens as potential diagnostic markers for pancreatic cancer
Evaluation of multiple autoantibodies to tumor-associated antigens as potential diagnostic markers for pancreatic cancer
The aim of the study is to evaluate the clinical significance of autoantibodies to GNA11, MSLN, GNAS, CEBPA, MDM2, p16, Sui1, Calnuc, PTEN in Pancreatic Cancer (PC). A total of 33 ...
e0683 Clinical significance of autoantibodies against cardiac troponin I in patients with myocardial infarction and chronic heart failure
e0683 Clinical significance of autoantibodies against cardiac troponin I in patients with myocardial infarction and chronic heart failure
Objective
Autoantibodies against cardiac troponin I (cTnI) have been described in the serum from patients with dialated cardiomyopathy and heart failure. The clin...

